Altogether, these results demonstrate that STAT3 activation can be detected in RM-9 prostate cancer cells in vitro and in vivo, and that M-HIFU reduces the levels of STAT3 activation and STAT3-targeted genes in RM-9 tumors. This evidence concerns the gene STAT3 and prostate cancer.